Home › Research › Cognitive tests and assessment
Tailored Dementia Care across Seven Swiss Memory Clinics: The CareMENS Model Improves Patients’ Mood and Quality of Life
Benedetta Leidi‐Maimone, Sophie Bugnon, Mélanie Bieler-Aeschlimann, Margaux Fumasoli, Alessa Hausmann, Delphine Frochaux, Mélanie Genetti Gatfield, Alexia Deslex-Maspero et al.. Neurodegenerative Diseases, 2025-08-18
Topic: Risk, prevention and care in population studies
Plain-language summary
anxiety and depression symptoms (HADS), functional autonomy (DAD-6), global cognition (MoCA), and quality of life (WHOQOL). Pre-post analyses were performed in 184 patients (median age: 74 years old; 53.3% women) assessed at baseline (T0) and, on average, 324.2 days later (T1). Changes over time were evaluated using a linear mixed-effects model. A retrospective standard care group (N = 165) of patients aged ≥50 years (median age: 74 years old; 53.9% women) and with a dementia severity score (CDR) ≤1 was included for comparison of HADS, DAD-6, and MoCA outcomes. The CareMENS model was successfully implemented into routine clinical practices of the participating memory clinics. Compared to standard care, the CareMENS intervention was associated with greater improvements in HADS-depression overall scores (-0.853, 95% CI = -1.441 to -0.265; p = 0.005) and in HADS-anxiety scores among patients with high baseline anxiety (-1.134, 95% CI = -2.134 to -0.133; p = 0.027). No significant between-groups differences were found in MoCA (0.361, 95% CI = -0.32 to 1.04; p = 0.299) and DAD-6 scores (0.892, 95% CI = -3.5 to 5.28; p = 0.69). Following the intervention, we observed positive within-group changes in the WHOQOL mean total score (+2.67, 95% CI = 1.31 to 4.02; p < 0.001) and particularly in the social participation subdomain (+6.1, 95% CI = 3.82 to 8.32; p < 0.001). These findings indicate that the CareMENS model of care can be effectively implemented into clinical settings. It showed a significant reduction in mood symptoms and suggested positive benefits for quality of life. Integrating care management models into memory clinics may enhance patient outcomes and represents a promising direction for the evolution of current memory clinic practice.
What this study adds
Evidence grade: Low
The record lists 165 participants. Compared with standard care, the CareMENS model was linked to greater improvement in depression scores and, in patients with high baseline anxiety, in anxiety scores. Reported effect size: 53.3%; 53.9%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Leidi‐Maimone, B., Bugnon, S., Bieler-Aeschlimann, M., Fumasoli, M., Hausmann, A., Frochaux, D., et al. (2025). Tailored Dementia Care across Seven Swiss Memory Clinics: The CareMENS Model Improves Patients’ Mood and Quality of Life. Neurodegenerative Diseases. https://doi.org/10.1159/000547932
Vancouver
Leidi‐Maimone B, Bugnon S, Bieler-Aeschlimann M, Fumasoli M, Hausmann A, Frochaux D, et al. Tailored Dementia Care across Seven Swiss Memory Clinics: The CareMENS Model Improves Patients’ Mood and Quality of Life. Neurodegenerative Diseases. 2025. doi:10.1159/000547932. PMID: 40825324.
BibTeX
@article{leidimaimone2025-40825324,
author = {Leidi‐Maimone, Benedetta and Bugnon, Sophie and Bieler-Aeschlimann, Mélanie and Fumasoli, Margaux and Hausmann, Alessa and Frochaux, Delphine and Gatfield, Mélanie Genetti and Deslex-Maspero, Alexia and others},
title = {{Tailored Dementia Care across Seven Swiss Memory Clinics: The CareMENS Model Improves Patients’ Mood and Quality of Life}},
journal = {Neurodegenerative Diseases},
year = {2025},
doi = {10.1159/000547932},
pmid = {40825324},
url = {https://doi.org/10.1159/000547932}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- anxiety and depression symptoms (HADS), functional autonomy (DAD-6), global cognition (MoCA), and quality of life (WHOQOL).
- Pre-post analyses were performed in 184 patients (median age: 74 years old; 53.3% women) assessed at baseline (T0) and, on average, 324.2 days later (T1).
- Changes over time were evaluated using a linear mixed-effects model.
- A retrospective standard care group (N = 165) of patients aged ≥50 years (median age: 74 years old; 53.9% women) and with a dementia severity score (CDR) ≤1 was included for comparison of HADS, DAD-6, and MoCA outcomes.
- The CareMENS model was successfully implemented into routine clinical practices of the participating memory clinics.
Why it matters
Compared with standard care, the CareMENS model was linked to greater improvement in depression scores and, in patients with high baseline anxiety, in anxiety scores. There were no significant differences in cognition or functional autonomy, so the model did not show a cognitive benefit.
Study details
- Participants165
- Effect size53.3%; 53.9%
- Evidence strengthLow
How this study scored 40/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Neurodegenerative Diseases) |
| Journal's citation record | 1 / 4 | Neurodegenerative Diseases: journal h-index 80 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 165 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 1 / 6 | Cited 0.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Andrea Brioschi Guevara: h-index 8 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Geneva: institution h-index 1,049 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 7 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40825324) |
| Free to read | 2 / 2 | Free to read |
| Total | 40 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1159/000547932
- PubMed: 40825324
- Original source →
- Free full text: Neurodegenerative Diseases →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Cognitive tests and assessment from nearby years
Also tagged “nursing”
995 studies in the library carry the topic tag “nursing”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 995 tagged studies.